Edition:
United States

People: Celgene Corp (CELG.O)

CELG.O on Nasdaq

113.06USD
8 Dec 2016
Change (% chg)

-- (--)
Prev Close
$113.06
Open
--
Day's High
--
Day's Low
--
Volume
144
Avg. Vol
4,464,687
52-wk High
$127.00
52-wk Low
$93.05

Cox, Carrie 

Ms. Carrie S. Cox serves as Independent Director of Celgene Corp. She is a member of the Audit Committee since March 2010. Ms. Cox currently serves as the Chairman of the Board of Directors and Chief Executive Officer of Humacyte, Inc., a privately-held regenerative medicine company primarily focused in developing products for vascular disease and for therapeutic filling and soft tissue repair. Ms. Cox served as Executive Vice President of Schering-Plough and President of Schering-Plough’s Global Pharmaceutical Business until November 3, 2009 when Schering-Plough merged with Merck & Co., Inc. Prior to joining Schering-Plough, Ms. Cox served as President of Pharmacia Corporation’s pharmaceutical business until its merger with Pfizer Inc. in 2003. Ms. Cox is a member of the Board of Directors of Texas Instruments and has served on their audit and compensation committees, and has been appointed to the Board of Directors of Cardinal Health, Inc. Ms. Cox is also a member of the Harvard School of Public Health’s Health Policy and Management Executive Council and a member of the Board of Overseers of the University of Pennsylvania Museum of Archaeology and Anthropology. Ms. Cox is a graduate of the Massachusetts College of Pharmacy.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Hugin

22,472,900

Jacqualyn Fouse

8,073,500

Mark Alles

7,912,170

Peter Kellogg

5,705,640

Thomas Daniel

7,341,980

Scott Smith

4,783,240
As Of  30 Dec 2015